These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 19270726)

  • 1. EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor.
    Li JJ; Liu DP; Liu GT; Xie D
    Oncogene; 2009 Apr; 28(15):1759-68. PubMed ID: 19270726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability.
    Wang TH; Chang JL; Ho JY; Wu HC; Chen TC
    FEBS J; 2012 Jan; 279(2):251-63. PubMed ID: 22074469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma.
    Wang TH; Ng KF; Yeh TS; Wang YL; Liang KH; Yeh CT; Chen TC
    PLoS One; 2012; 7(7):e41749. PubMed ID: 22860012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
    Liu DP; Wang Y; Koeffler HP; Xie D
    Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
    Geoerger B; Gaspar N; Opolon P; Morizet J; Devanz P; Lecluse Y; Valent A; Lacroix L; Grill J; Vassal G
    Int J Cancer; 2008 Jul; 123(1):209-16. PubMed ID: 18386816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
    Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
    Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
    Jukonen J; Moyano-Galceran L; Höpfner K; Pietilä EA; Lehtinen L; Huhtinen K; Gucciardo E; Hynninen J; Hietanen S; Grénman S; Ojala PM; Carpén O; Lehti K
    Sci Rep; 2021 Apr; 11(1):8856. PubMed ID: 33893375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent and divergent signaling mechanisms of growth cone collapse by ephrinA5 and slit2.
    Wong EV; Kerner JA; Jay DG
    J Neurobiol; 2004 Apr; 59(1):66-81. PubMed ID: 15007828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OncomiR miR-96 and miR-182 promote cell proliferation and invasion through targeting ephrinA5 in hepatocellular carcinoma.
    Wang TH; Yeh CT; Ho JY; Ng KF; Chen TC
    Mol Carcinog; 2016 Apr; 55(4):366-75. PubMed ID: 25663355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized.
    Padrón D; Sato M; Shay JW; Gazdar AF; Minna JD; Roth MG
    Cancer Res; 2007 Aug; 67(16):7695-702. PubMed ID: 17699773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on the role of different ephrins in glioma.
    Zhu B; Li Y; Mao X
    Eur J Pharmacol; 2022 Feb; 917():174588. PubMed ID: 34688637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deleterious c-Cbl Exon Skipping Contributes to Human Glioma.
    Seong MW; Ka SH; Park JH; Park JH; Yoo HM; Yang SW; Park JM; Park D; Lee ST; Seol JH; Chung CH
    Neoplasia; 2015 Jun; 17(6):518-24. PubMed ID: 26152360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme.
    Liu KJ; Chen CT; Hu WS; Hung YM; Hsu CY; Chuang BF; Juang SH
    Int J Oncol; 2004 Mar; 24(3):581-90. PubMed ID: 14767543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expression of the Cancer-Associated lncRNA
    Pensold D; Gehrmann J; Pitschelatow G; Walberg A; Braunsteffer K; Reichard J; Ravaei A; Linde J; Lampert A; Costa IG; Zimmer-Bensch G
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
    Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
    Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ubiquitination-mediated degradation of epidermal growth factor receptor].
    Xiu X; Lü ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):120-7. PubMed ID: 15782507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.
    Guillamo JS; de Boüard S; Valable S; Marteau L; Leuraud P; Marie Y; Poupon MF; Parienti JJ; Raymond E; Peschanski M
    Clin Cancer Res; 2009 Jun; 15(11):3697-704. PubMed ID: 19435839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro.
    Reissenweber B; Mosch B; Pietzsch J
    Melanoma Res; 2013 Apr; 23(2):85-95. PubMed ID: 23358429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo expression of ephrinA5-Fc in mice results in cephalic neural crest agenesis and craniofacial abnormalities.
    Noh H; Park E; Park S
    Mol Cells; 2014 Jan; 37(1):59-65. PubMed ID: 24552711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.